CB Insights October 29, 2019
We visualize where leading tech companies are placing strategic bets on healthcare startups across clinical research, genetics, drug delivery, and more.
Healthcare is an enormous — and inefficient — industry.
In the US, healthcare represents 19% of national GDP, but 20% – 25% of healthcare spending is waste, according to some research estimates.
These inefficiencies are visible across the industry: there are over 175K medical coding professionals working to ensure doctors and hospitals get paid; the average cost of bringing a new drug to market is now a whopping $2.5B; and the cost of employer-based coverage is now over $20K a year.